Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination analgesic containing ibuprofen (a non-steroidal anti-inflammatory drug), paracetamol (acetaminophen, a non-opioid analgesic), and codeine (an opioid analgesic). This triple combination would be used for moderate to severe pain relief. Each component works through different mechanisms: ibuprofen inhibits prostaglandin synthesis, paracetamol acts centrally, and codeine affects pain receptors in the central nervous system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ibuprofen + paracetamol + codeine.